(Q43607131)

25 November 2017

Metformin and the risk of endometrial cancer: a population-based cohort study (English)

1 reference

25 November 2017

1 reference

1 reference

2

Til Stürmer

1 reference

25 November 2017

6

Michele Jonsson Funk

1 reference

25 November 2017

Emily M Ko

1

1 reference

25 November 2017

Jin-Liern Hong

series ordinal

3

1 reference

25 November 2017

Wendy Camelo Castillo

series ordinal

4

1 reference

25 November 2017

Victoria Bae-Jump

series ordinal

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

8 December 2014

1 reference

25 November 2017

1 reference

25 November 2017

136

1 reference

25 November 2017

2

1 reference

25 November 2017

341-347

1 reference

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Pharmacologic therapy of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Investigating metformin for cancer prevention and treatment: the end of the beginning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Antidiabetic therapies affect risk of pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Long-term metformin use is associated with decreased risk of breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Antidiabetes drugs correlate with decreased risk of lung cancer: a population-based observation in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin and the risk of cancer: time-related biases in observational studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin is associated with improved survival in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin use and endometrial cancer survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Body size in relation to cancer of the uterine corpus in 1 million Norwegian women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Diabetes and risk of endometrial cancer: a population-based prospective cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Diabetes mellitus and risk of endometrial cancer: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Type I and II endometrial cancers: have they different risk factors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Endometrial cancer: a review and current management strategies: part I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

The central role of the propensity score in observational studies for causal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Metformin and the risk of endometrial cancer: a case-control analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Association between diabetes, diabetes treatment and risk of developing endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2014.12.001

10.1016/J.YGYNO.2014.12.001

7 January 2021

Identifiers

DOI

1 reference

release_mjodbxqsuzbwfoaahfqwptul4e

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mjodbxqsuzbwfoaahfqwptul4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference